Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

July 01, 1992; Volume 42,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abramson, R

    1. You have access
      Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;
  2. Adam, M

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;
  3. Asano, Y

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

B

  1. Barber, R

    1. You have access
      Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;
  2. Barsh, G

    1. You have access
      Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;
  3. Bell, G I

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;
  4. Bhushan, A

    1. You have access
      Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;
  5. Billingsley, M L

    1. You have access
      Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;
  6. Blaxall, H S

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;
  7. Boteju, L W

    1. You have access
      Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;
  8. Brach, M A

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;
  9. Butcher, R W

    1. You have access
      Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;
  10. Butt, E

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  11. Bylund, D B

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

C

  1. Calvo, S

    1. You have access
      Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;
  2. Caron, M G

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;
  3. Ceña, V

    1. You have access
      Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;
  4. Chakinala, M M

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  5. Charleson, S

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;
  6. Cheon, H G

    1. You have access
      Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;
  7. Chiu, J F

    1. You have access
      Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;
  8. Chruscinski, A

    1. You have access
      Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;
  9. Clark, R B

    1. You have access
      Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;
  10. Coppolino, M G

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;
  11. Corbin, J D

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  12. Costa, T

    1. You have access
      Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;

D

  1. Daunt, D

    1. You have access
      Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;
  2. De Vos, S

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;
  3. Dichter, M A

    1. You have access
      Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;

E

  1. Evans, J F

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

F

  1. Francis, S H

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  2. Fraser, C M

    1. You have access
      Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;

G

  1. Goka, T J

    1. You have access
      Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;
  2. González-García, C

    1. You have access
      Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
      S Calvo, C González-García and V Ceña
      Molecular Pharmacology July 1992, 42 (1) 141-146;
  3. Gruss, H J

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

H

  1. Hanna, P E

    1. You have access
      Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
      H G Cheon, L W Boteju and P E Hanna
      Molecular Pharmacology July 1992, 42 (1) 82-93;
  2. Hatchett, R J

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  3. Herrmann, F

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;

I

  1. Iversen, L J

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

J

  1. Jacobson, K A

    1. You have access
      Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;
  2. Jani, J P

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;
  3. Jastorff, B

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  4. Ji, X D

    1. You have access
      Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;

K

  1. Kamboj, R K

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
  2. Kim, S G

    1. You have access
      Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation.
      S G Kim and Y H Kim
      Molecular Pharmacology July 1992, 42 (1) 75-81;
  3. Kim, Y H

    1. You have access
      Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation.
      S G Kim and Y H Kim
      Molecular Pharmacology July 1992, 42 (1) 75-81;
  4. Kobilka, B

    1. You have access
      Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;
  5. Korczak, B

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
  6. Krady, J K

    1. You have access
      Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;

L

  1. Law, S F

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;
  2. Lazarovici, P

    1. You have access
      Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;
  3. Lazo, J S

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;
  4. Lefkowitz, R J

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;
  5. Lester, D

    1. You have access
      Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;
  6. Link, R

    1. You have access
      Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
      R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
      Molecular Pharmacology July 1992, 42 (1) 16-27;
  7. Lomasney, J W

    1. You have access
      Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
      D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
      Molecular Pharmacology July 1992, 42 (1) 1-5;

M

  1. MacDonald, R L

    1. You have access
      Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
      D M Rock and R L MacDonald
      Molecular Pharmacology July 1992, 42 (1) 157-164;
  2. Mancini, J A

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;
  3. Matsuda, Y

    1. You have access
      Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;
  4. Mignano, J E

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;
  5. Miledi, R

    1. You have access
      Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;
  6. Mistry, J S

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;
  7. Molinoff, P B

    1. You have access
      Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;
  8. Morris, G

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;

N

  1. Nishizaki, T

    1. You have access
      Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking.
      T Nishizaki and K Sumikawa
      Molecular Pharmacology July 1992, 42 (1) 152-156;
  2. Nutt, S

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

O

  1. Ogino, Y

    1. You have access
      Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
      Y Ogino, C M Fraser and T Costa
      Molecular Pharmacology July 1992, 42 (1) 6-9;
  2. Olianas, M C

    1. You have access
      Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology July 1992, 42 (1) 109-115;
  3. Onali, P

    1. You have access
      Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology July 1992, 42 (1) 109-115;

P

  1. Polenzani, L

    1. You have access
      Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;
  2. Proll, M A

    1. You have access
      Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
      M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
      Molecular Pharmacology July 1992, 42 (1) 116-122;

R

  1. Rahamim, E

    1. You have access
      Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;
  2. Rasouly, D

    1. You have access
      Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
      D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
      Molecular Pharmacology July 1992, 42 (1) 35-43;
  3. Reisine, T

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;
  4. Rens-Domiano, S

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;
  5. Riedel, D

    1. You have access
      Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
      M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
      Molecular Pharmacology July 1992, 42 (1) 63-68;
  6. Rock, D M

    1. You have access
      Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
      D M Rock and R L MacDonald
      Molecular Pharmacology July 1992, 42 (1) 157-164;

S

  1. Sandig, P

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  2. Schmitz, W

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  3. Schoepp, D D

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
  4. Scholz, H

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  5. Scholz, J

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  6. Schulte Am Esch, J

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  7. Sebti, S M

    1. You have access
      Neutralization of bleomycin hydrolase by an epitope-specific antibody.
      G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
      Molecular Pharmacology July 1992, 42 (1) 57-62;
  8. Seino, S

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;
  9. Sekhar, K R

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  10. Shabb, J B

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  11. Shekter, L

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
  12. Stiles, G L

    1. You have access
      Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
      K A Jacobson, G L Stiles and X D Ji
      Molecular Pharmacology July 1992, 42 (1) 123-133;
  13. Sumikawa, K

    1. You have access
      Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking.
      T Nishizaki and K Sumikawa
      Molecular Pharmacology July 1992, 42 (1) 152-156;

T

  1. Toggas, S M

    1. You have access
      Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
      S M Toggas, J K Krady and M L Billingsley
      Molecular Pharmacology July 1992, 42 (1) 44-56;
  2. Tritton, T R

    1. You have access
      Expression of c-fos in human and murine multidrug-resistant cells.
      A Bhushan, R Abramson, J F Chiu and T R Tritton
      Molecular Pharmacology July 1992, 42 (1) 69-74;
  3. Troll, U

    1. You have access
      Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
      J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
      Molecular Pharmacology July 1992, 42 (1) 134-140;
  4. True, R A

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

V

  1. Vickers, P J

    1. You have access
      Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
      P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
      Molecular Pharmacology July 1992, 42 (1) 94-102;

W

  1. Wells, J N

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  2. Williams, K

    1. You have access
      Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
      K Williams, M A Dichter and P B Molinoff
      Molecular Pharmacology July 1992, 42 (1) 147-151;
  3. Wolfe, L

    1. You have access
      Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
      K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
      Molecular Pharmacology July 1992, 42 (1) 103-108;
  4. Woodward, R M

    1. You have access
      Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology July 1992, 42 (1) 165-173;
  5. Wosnick, M A

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;

Y

  1. Yamada, Y

    1. You have access
      Pharmacological properties of two cloned somatostatin receptors.
      S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
      Molecular Pharmacology July 1992, 42 (1) 28-34;

Z

  1. Zimmerman, D M

    1. You have access
      Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
      R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
      Molecular Pharmacology July 1992, 42 (1) 10-15;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 42, Issue 1
1 Jul 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics